Occupational exposure limit for silver nanoparticles: considerations on the derivation of a general health-based value

References

• ACGIH (American Conference of Governmental Industrial Hygienists). 2013. TLVs and BEIs. Cincinnati, OH: ACGIH.
   Google Scholar
• Allen BC, Kavlock RJ, Kimmel CA, Faustman EM. 1994. Dose–response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. Fundam Appl Toxicol 23:487–95.
   PubMedGoogle Scholar
• Aschberger K, Johnston HJ, Stone V, Aitken RJ, Hankin SM, Peters SA, et al. 2010. Review of carbon nanotubes toxicity and exposure-appraisal of human health risk assessment based on open literature. Crit Rev Toxicol 40:759–90.
   PubMed Web of Science ®Google Scholar
• Asgharian B, Price O, Miller F, Subramaniam R, Cassee FR, Freijer J, et al. 2009. Multiple-Path Particle Dosimetry Model (MPPD v2.11): A Model for Human and Rat Airway Particle Dosimetry. In Hamner Institutes for Health Sciences Applied Research Associates (ARA), National Institute for Public Health and the Environment (RIVM), and Ministry of Housing, Spatial Planning and the Environment, editor. Raleigh, NC: Applied Research Associates (ARA).
   Google Scholar
• AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. 2009. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3:279–90.
   PubMed Web of Science ®Google Scholar
• Borm P, Cassee FR, Oberdorster G. 2015. Lung particle overload: old school -new insights? Part Fibre Toxicol 12:10.
   PubMed Web of Science ®Google Scholar
• Boudreau MD, Imam MS, Paredes AM, Bryant MS, Cunningham CK, Felton RP, et al. 2016. Differential effects of silver nanoparticles and silver ions on tissue accumulation, distribution, and toxicity in the Sprague–Dawley rat following daily oral gavage administration for 13-weeks. Toxicol Sci, published on line.
   Google Scholar
• Braakhuis HM, Gosens I, Krystek P, Boere JA, Cassee FR, Fokkens PH, et al. 2014. Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles. Part Fibre Toxicol 11:49
   PubMed Web of Science ®Google Scholar
• Brown JS, Wilson WE, Grant LD. 2005. Dosimetric comparisons of particle deposition and retention in rats and humans. Inhal Toxicol 17:355–85.
   PubMed Web of Science ®Google Scholar
• Catsakis LH, Sulica VI. 1978. Allergy to silver amalgams. Oral Surg Oral Med Oral Pathol 46:371–5.
   PubMedGoogle Scholar
• Cho EA, Lee WS, Kim KM, Kim SY. 2008. Occupational generalized argyria after exposure to aerosolized silver. J Dermatol 35:759–60.
   PubMed Web of Science ®Google Scholar
• Cho HS, Sung JH, Song KS, Kim JS, Ji JH, Lee JH, et al. 2013. Genotoxicity of silver nanoparticles in lung cells of Sprague Dawley rats after 12 weeks of inhalation exposure. Toxics 1:36–45.
   Google Scholar
• Cho KH, Park JE, Osaka T, Park SG. 2005. The study of antimicrobial activity and preservative effects of nanosilver ingredient. Electrochim Acta 51:956–60.
   Web of Science ®Google Scholar
• Davis JA, Gift JS, Zao QJ. 2011. Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1. Toxicol Appl Pharmacol 254:181–91.
   PubMed Web of Science ®Google Scholar
• de Winter-Sorkina R, Cassee FR. 2003. From concentration to dose: factors influencing airborne particulate matter deposition in humans and rats, Report No. 650010031. Bilthoven, The Netherlands: Netherlands National Institute for Public Health and the Environment (RIVM).
   Google Scholar
• DFG (Deutsche Forschungsgemeinschaft). 2006. MAK- und BAT-Werte-Liste, Deutsche Forschungsgemeinschaft. Weinheim, Germany: Wiley-VCH,
   Google Scholar
• ECHA (European Chemicals Agency). 2012. Occupational exposure estimation. In: Guidance on Information Requirements and Chemical Safety Assessment. Helsinki, Finland: European Chemicals Agency (Chapter R.14).
   Google Scholar
• Faustman EM1, Allen BC, Kavlock RJ, Kimmel CA. 1994. Dose–response assessment for developmental toxicity. I. Characterization of database and determination of no observed adverse effect levels. Fundam Appl Toxicol 23:478–86.
   PubMedGoogle Scholar
• Foldbjerg R, Dang DA, Autrup H. 2011. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol 85:743–50.
   PubMed Web of Science ®Google Scholar
• Geiser M, Kreyling WG. 2010. Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol 7:2
   PubMed Web of Science ®Google Scholar
• Gregoratto D, Bailey MR, Marsh JW. 2010. Modelling particle retention in the alveolar–interstitial region of the human lungs. J Radiol Prot 30:491–512.
   PubMed Web of Science ®Google Scholar
• Hadrup N, Lam HR. 2014. Oral toxicity of silver ions, silver nanoparticles and colloidal silver – a review. Regul Toxicol Pharmacol 68:1–7.
   PubMed Web of Science ®Google Scholar
• Heyl T. 1979. Contact dermatitis from silver coat. Contact Dermatitis 5:197.
   PubMed Web of Science ®Google Scholar
• ICRP (International Commission on Radiologic Protection). 1994. Human respiratory tract model for radiological protection. Oxford, England: Pergamon, Elsevier Science Ltd., International Commission on Radiological Protection Publication No. 66.
   Google Scholar
• ISO TS 80004-2. 2015. Nanotechnologies-Vocabulary – Part 2: Nano-objects. Geneva: ISO.
   Google Scholar
• Jarabek AM, Asgharian B, Miller FJl. 2005. Dosimetric adjustments for interspecies extrapolation of inhaled poorly soluble particles (PSP). Inhal Toxicol 17:317–34.
   PubMed Web of Science ®Google Scholar
• Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, et al. 2007. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague–Dawley rats. Inhal Toxicol 19:857–71.
   PubMed Web of Science ®Google Scholar
• Kavlock RJ, Allen BC, Faustman EM, Kimmel CA. 1995. Dose–response assessments for developmental toxicity. IV. Benchmark doses for fetal weight changes. Fundam Appl Toxicol 26:211–22.
   PubMedGoogle Scholar
• Keller J, Wohlleben W, Ma-Hock L, Strauss V, Gröters S, Küttler K, et al. 2014. Time course of lung retention and toxicity of inhaled particles: short-term exposure to nano-Ceria. Arch Toxicol 88:2033–59.
   PubMed Web of Science ®Google Scholar
• Kim JS, Song KS, Sung JH, Ryu HR, Choi BG, Cho HS, et al. 2013. Genotoxicity, acute oral and dermal toxicity, eye and dermal irritation and corrosion and skin sensitisation evaluation of silver nanoparticles. Nanotoxicology 7:953–60.
   PubMed Web of Science ®Google Scholar
• Kim JS, Sung JH, Ji JH, Song KS, Lee JH, Kang CS, et al. 2011. In vivo genotoxicity of silver nanoparticles after 90-day silver nanoparticle inhalation exposure. Saf Health Work 2:34–8.
   PubMedGoogle Scholar
• Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, et al. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague–Dawley rats. Inhalat Toxicol 20:575–83.
   PubMed Web of Science ®Google Scholar
• Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, et al. 2010. Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol 7:20.
   PubMed Web of Science ®Google Scholar
• Kimmel CA, Kavlock RJ, Allen BC, Faustman EM. 1995. The application of benchmark dose methodology to data from prenatal developmental toxicity studies. Toxicol Lett 82-83:549–54.
   PubMed Web of Science ®Google Scholar
• Landsiedel R, Fabian E, Ma-Hock L, van Ravenzwaay B, Wohlleben W, Wiench K, et al. 2012. Toxico-/biokinetics of nanomaterials. Arch Toxicol 86:1021–60.
   PubMed Web of Science ®Google Scholar
• Lankveld DP, Oomen AG, Krystek P, Neigh A, Troost – de Jong A, Noorlander CW, et al. 2010. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 31:8350–61.
   PubMed Web of Science ®Google Scholar
• Lee JH, Ahn K, Kim SM, Jeon KS, Lee JS, Yu IJl. 2012b. Continuous 3-day exposure assessment of workplace manufacturing silver nanoparticles. J Nanopart Res 14:1134.
   Web of Science ®Google Scholar
• Lee JH, Kim YS, Song JS, Ryu HR, Sung JH, Park JD, et al. 2013a. Biopersistence of silver nanoparticles in tissues from Sprague–Dawley rats. Part Fibre Toxicol 10:36.
   PubMed Web of Science ®Google Scholar
• Lee JH, Kwon M, Ji JH, Kang CS, Ahn KH, Han JH, et al. 2011. Exposure assessment of workplaces manufacturing nanosized TiO2 and silver. Inhalat Toxicol 23:226–36.
   PubMed Web of Science ®Google Scholar
• Lee JH, Mun J, Park JD, Yu IJ. 2012a. A health surveillance case study on workers who manufacture silver nanomaterials. Nanotoxicology 6:667–9.
   PubMed Web of Science ®Google Scholar
• Lee JH, Sohn EK, Ahn JS, Ahn K, Kim KS, Lee JH, et al. 2013b. Exposure assessment of workers in printed electronics workplace. Inhalat Toxicol 25:426–34.
   PubMed Web of Science ®Google Scholar
• Leo BF, Chen S, Kyo Y, Herpoldt KL, Terrill NJ, Dunlop IE, et al. 2013. The stability of silver nanoparticles in a model of pulmonary surfactant. Environ Sci Technol 47:11232–40.
   PubMed Web of Science ®Google Scholar
• Li P, Li J, Wu C, Wu Q, Li J. 2005. Synergistic antibacterial effects of beta-lactam antibiotic combined with silver nanoparticles. Nanotechnology 16:1912–17.
   Web of Science ®Google Scholar
• Li X, Lenhart JJ, Walker HW. 2012. Aggregation kinetics and dissolution of coated silver nanoparticles. Langmuir 28:1095–1104.
   PubMed Web of Science ®Google Scholar
• Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U, et al. 2011. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 8:18.
   PubMed Web of Science ®Google Scholar
• Ma R, Levard C, Marinakos SM, Cheng Y, Liu J, Michel FM, et al. 2012. Size-controlled dissolution of organic-coated silver nanoparticles. Environ Sci Technol 46:752–9.
   PubMed Web of Science ®Google Scholar
• Marks R. 1966. Contact dermatitis due to silver. Br J Dermatol 78:606–7.
   PubMed Web of Science ®Google Scholar
• Maronpot RR. 2014. Liver, Bile Duct – Hyperplasia. National Toxicology Program Nonneoplastic Lesion Atlas. Available at: http://ntp.niehs.nih.gov/nnl/hepatobiliary/liver/bdhyperp/index.htm. Accessed on 7 January 2015.
   Google Scholar
• Miller FJ, Kimbell JS, Preston RJ, Overton JH, Gross EA, Conolly RB. 2011. The fractions of respiratory tract cells at risk in formaldehyde carcinogenesis. Inhalat Toxicol 23:689–706.
   PubMed Web of Science ®Google Scholar
• Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JT, et al. 2005. The bactericidal effect of silver nanoparticles. Nanotechnology 16:2346–53.
   PubMed Web of Science ®Google Scholar
• NIOSH (National Institute for Occupational Safety and Health). 2013. Occupational Exposure to Carbon Nanotubes and Nanofibers. Current Intelligence Bulletin 65. Cincinnati, OH: NIOSH.
   Google Scholar
• OECD (Organisation for Economic Co-operation and Development), 2010. Report of the Workshop on Risk Assessment of Manufactured Nanomaterials in a regulatory context. No. 21 – ENV/JM/MONO(2010)10. Paris: OECD.
   Google Scholar
• OECD. 2014. Genotoxicity of Manufactured Nanomaterials: Report of the OECD Expert Meeting. ENV/JM/MONO(2014)34. Paris: OECD.
   Google Scholar
• Oller AR, Oberdorster G. 2010. Incorporation of particle size differences between animal studies and human workplace aerosols for deriving exposure limit values. Regulat Toxicol Pharmacol 57:181–94.
   PubMed Web of Science ®Google Scholar
• Park EJ, Bae E, Yi J, Kim Y, Choi K, Lee SH, et al. 2010. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ Toxicol Pharmacol 30:162–8.
   PubMed Web of Science ®Google Scholar
• Park J, Kwak BK, Bae E, Lee J, Kim Y, Choi K, et al. 2009. Characterization of exposure to silver nanoparticles in a manufacturing facility. J Nanopart Res 11:1705–12.
   Web of Science ®Google Scholar
• Park K, Park EJ, Chun IK, Choi K, Lee SH, Yoon J, Lee BC. 2011. Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats. Arch Pharm Res 34:153–8.
   PubMed Web of Science ®Google Scholar
• Pauluhn J. 2010. Multi-walled carbon nanotubes (Baytubes): approach for derivation of occupational exposure limit. Regul Toxicol Pharmacol 57:78–89.
   PubMed Web of Science ®Google Scholar
• Quadros ME, Marr LC. 2010. Environmental and human health risks of aerosolized silver nanoparticles. J Air Waste Manag Assoc 60:770–81.
   PubMedGoogle Scholar
• SCENIHR. 2014. Nanosilver: safety, health and environmental effects and role in antimicrobial resistance. Scientific Committee on Emerging and Newly Identified Health Risks. Available at: http://ec.europa.eu/health/scientific_committees/consultations/public_consultations/scenihr_consultation_17_en.htm. Accessed on 7 January 2015.
   Google Scholar
• Schäfer B, Brocke JV, Epp A, Götz M, Herzberg F, Kneuer C, et al. 2013. State of the art in human risk assessment of silver compounds in consumer products: a conference report on silver and nanosilver held at the BfR in 2012. Arch Toxicol 87:2249–62.
   PubMed Web of Science ®Google Scholar
• Slob W. 2002. Dose–response modeling of continuous endpoints. Toxicol Sci 66:298–312.
   PubMed Web of Science ®Google Scholar
• Snipes MB. 1989. Long-term retention and clearance of particles inhaled by mammalian species. Crit Rev Toxicol 20:175–211.
   PubMed Web of Science ®Google Scholar
• Sondi I, Salopek-Sondi B. 2004. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275:177–82.
   PubMed Web of Science ®Google Scholar
• Song KS, Sung JH, Ji JH, Lee JH, Lee JS, Ryu HR, et al. 2013. Recovery from silver-nanoparticle-exposure-induced lung inflammation and lung function changes in Sprague Dawley rats. Nanotoxicology 7:169–80.
   PubMed Web of Science ®Google Scholar
• Stebounova LV, Adamcakova-Dodd A, Kim JS, Park H, O'Shaughnessy PT, Grassian VH, et al. 2011. Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Part Fibre Toxicol 8:5
   PubMed Web of Science ®Google Scholar
• Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, et al. 2009. Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 108:452–61.
   PubMed Web of Science ®Google Scholar
• Sung JH, Ji JH, Song KS, Lee JH, Choi KH, Lee SH, et al. 2011. Acute inhalation toxicity of silver nanoparticles. Toxicol Ind Health 27:149–54.
   PubMed Web of Science ®Google Scholar
• Sung JH, Ji JH, Yoon JU, Kim DS, Song MY, Jeong J, et al. 2008. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal Toxicol 20:567–74.
   PubMed Web of Science ®Google Scholar
• SUVA, 2007. Grenzwerte am Arbeitsplatz, Schweizerische Unfallversicherungsanstalt. Luzern, Germany
   Google Scholar
• US EPA. 1994. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry, Research Triangle Park, NC: USEPA.
   Google Scholar
• US EPA. 2012. Benchmark Dose Technical Guidance. Washington, DC, United States Environmental Protection Agency. Research Triangle Park, NC, USEPA
   Google Scholar
• USEPA. 2015. Benchmark Dose Software Version 2.6.0. Available at: http://www2.epa.gov/bmds.
   Google Scholar
• Utembe W, Potgieter K, Stefaniak AB, Gulumian M. 2015. Dissolution and biodurability: important parameters needed for risk assessment of nanomaterials. Part Fibre Toxicol 12:11
   PubMed Web of Science ®Google Scholar
• van der Zande M, Vandebriel RJ, Van Der Zande M, Vandebriel RJ, Van Doren E, Kramer E, Herrera Rivera Z, Serrano-Rojero CS, et al. 2012. “Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure”. ACS Nano 6:7427–42.
   PubMed Web of Science ®Google Scholar
• Walczak AP, Fokkink R, Peters R, Tromp P, Herrera Rivera ZE, Rietjens IM, et al. 2013. Behaviour of silver nanoparticles and silver ions in an in vitro human gastrointestinal digestion model. Nanotoxicology 7:1198–210.
   PubMed Web of Science ®Google Scholar
• Wignall JA, Shapiro AJ, Wright FA, Woodruff TJ, Chiu WA, Guyton KZ, et al. 2014. Standardizing benchmark dose calculations to improve science-based decisions in human health assessments. Environ Health Perspect 122:499–505.
   PubMed Web of Science ®Google Scholar
• Woodrow Wilson International Center for Scholars, W. 2015. The project on emerging nanotechnologies. Available at: http://www.nanotechproject.org/inventories/.
   Google Scholar